Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Stimulant medications: how to minimize their reinforcing effects?

Volkow ND.

Am J Psychiatry. 2006 Mar;163(3):359-61. No abstract available.

PMID:
16513852
2.

Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.

Volkow ND, Swanson JM.

Am J Psychiatry. 2003 Nov;160(11):1909-18. Review.

PMID:
14594733
4.
5.
6.

Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.

Volkow ND, Fowler JS, Wang GJ, Ding YS, Gatley SJ.

Eur Neuropsychopharmacol. 2002 Dec;12(6):557-66. Review.

PMID:
12468018
7.

Is there stimulant sensitivity in children?

Klein R, Mannuzza S.

J Atten Disord. 2002;6 Suppl 1:S61-3.

PMID:
12685520
8.

Mechanism of action of methylphenidate: insights from PET imaging studies.

Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ.

J Atten Disord. 2002;6 Suppl 1:S31-43.

PMID:
12685517
9.

Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.

Pae CU.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1149-50; author reply 1151-2. Epub 2007 Apr 1. No abstract available.

PMID:
17493730
10.

Pharmacology of adult ADHD with stimulants.

Spencer TJ.

CNS Spectr. 2007 Apr;12(4 Suppl 6):8-11. No abstract available.

PMID:
17715564
11.

[The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].

Frölich J, Banaschewski T, Spanagel R, Döpfner M, Lehmkuhl G.

Z Kinder Jugendpsychiatr Psychother. 2012 Sep;40(5):287-99; quiz 299-300. doi: 10.1024/1422-4917/a000185. German.

PMID:
22869222
12.

Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.

Leonard BE, McCartan D, White J, King DJ.

Hum Psychopharmacol. 2004 Apr;19(3):151-80. Review. No abstract available.

PMID:
15079851
13.

Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.

Lewis H, Lewis J.

Atten Defic Hyperact Disord. 2012 Mar;4(1):37-9. doi: 10.1007/s12402-012-0071-9. Epub 2012 Feb 5.

PMID:
22311620
14.

Impact of withdrawal of Ritalin LA in the Western Cape.

Donker Fv, Riordan G, Wilmshurst J.

S Afr Med J. 2008 Aug;98(8):570. No abstract available.

PMID:
18928026
15.

Dexmethylphenidate (Focalin) for ADHD.

[No authors listed]

Med Lett Drugs Ther. 2002 May 13;44(1130):45-6. No abstract available.

PMID:
12011757
16.

[Methylphenidate misuse].

Bruggisser M, Bodmer M, Liechti ME.

Praxis (Bern 1994). 2012 Feb 29;101(5):299-305. doi: 10.1024/1661-8157/a000856. Review. German.

PMID:
22377977
18.

Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.

Kraemer M, Uekermann J, Wiltfang J, Kis B.

Clin Neuropharmacol. 2010 Jul;33(4):204-6. doi: 10.1097/WNF.0b013e3181e29174. Review.

PMID:
20571380
19.

The effects of stimulant medications for ADHD.

[No authors listed]

Natl Bur Econ Res Bull Aging Health. 2014;(1):1-2. No abstract available.

PMID:
25141389
20.

Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.

Merkel RL Jr, Kuchibhatla A.

Expert Opin Drug Saf. 2009 Nov;8(6):655-68. doi: 10.1517/14740330903279956. Review.

PMID:
19785509

Supplemental Content

Support Center